Image - Barts and The London logo and link to home page Image - divider Image - divider
 
 
Image - Microscopes and Fib on HA scaffold
  link Home link Staff link Courses link Stem Cell research link Centres link Core facilities link BICMS Graduate School link Contact us

In this area:

 
Professor Stephen A Bustin BA, PhD
Professor of Molecular Science

 

 

Publications since 2001

•  Van Trappen, PO, Gyselman, VG, Lowe, DG, Ryan, A, Oram, DH, Bosze, P, Weekes, AR, Shepherd, JH, Dorudi, S, Bustin, SA, Jacobs, I.J. ( 2001 ) Molecular quantification and mapping of lymph-node micrometastases in cervical cancer Lancet 357: 15-20

•  Korbonits, M, Bustin , SA , Kojima, M, Jordan , S, Adams, EF, Lowe, DG, Kangawa, K, Grossman AB ( 2001 ) The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors. J Clin Endocrinol and Metabolism 86:881-887

•  Bustin, SA, Jenkins, PJ ( 2001 ) The growth hormone/insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 7 447-454

•  Miraki-Moud F, Jenkins PJ, Fairclough PD, Jordan S, Bustin SA, Jones AM, Lowe DG, Monson JP, Grossman AB , Besser GM, Camacho-Hubner C. ( 2001 ) Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly. Clin Endocrinol 54:499-508

•  Bustin, SA, Li SR, Phillips, S, Dorudi S ( 2001 ) Expression of HLA class II in colorectal cancer: evidence for enhanced immunogenicity of MSI + tumours. Tumor Biol. 22:294-298

•  Bustin, SA, Li SR, Dorudi S ( 2001 ) Expression of the Ca 2+ -activated Chloride Channel genes CLCA1 and CLCA2 is down-regulated in human colorectal cancer. DNA Cell Biol 20 331-338

•  Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA , Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA ( 2002 ) Vitamin D receptor mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity and VDR genotype in Bangladeshi Asians. Diabetes 51:2294-2300

•  Tricarico, C, Pinzani, P, Bianchi, S, Paglierani, M, Distante, V, Pazzagli, M, Bustin, SA , Orlando , C. ( 2002 ) Quantitative real-time RT-PCR: Normalisation to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem . 309:293-300

•  Kirkpatrick KL, Ogunkolade W, Elkak A, Bustin SA , Jenkins P, Ghilchik M, Mokbel K. ( 2002 ) The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin 18:237-241

•  Bustin, SA ( 2002 ) Quantification of mRNA using real-time RT-PCR: trends and problems. J Mol Endocrinol 29:23-39

•  Bustin, SA and Dorudi, S ( 2002 ) The value of quantitative gene profiling data for molecular diagnostics. Trends Mol Med 8:269-272

•  Bustin, SA ( 2002 ) Nucleic Acid-Based Technologies: time to stop and think. Exp Rev Mol Diagn . 2:89-92

•  Bustin, SA, Dorudi S, Phillips, S, Feakins, R, Jenkins, PJ ( 2002 ) Local effects of insulin-like growth factor-I in normal colon and in colorectal cancer. Tumor Biol. 23:130-138

•  Gnanapavan, S, Kola, B, Bustin, SA , Morris, DG, McGee, P, Fairclough, P, Carpenter, R, Grossman AB, Korbonits M ( 2002 ) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans J Clin Endocrinol and Metabolism 87:2988-2991

•  Ogunkolade, BW, Boucher, BJ, Fairclough, PD, Hitman, HA, Durudi, S, Jenkins, PJ, Bustin, SA ( 2002 ) Down-regulation of 25-hydroxyvitamin D-1-a-hydroxylase in normal colonic mucosa of Patients with colorectal cancer. Lancet 359:1831-1832.

•  Kirkpatrick KL, Ogunkolade W, Elkak AE, Bustin SA , Jenkins P, Ghilchik M, Newbold, RF, Mokbel K. ( 2003 ) hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Canc Res and Treat 77:277-284

•  Li, S.-R, Dorudi, S, Bustin SA. ( 2003 ) Identification of differentially expressed genes associated with colorectal cancer liver metastases. Eur Surgical Res 35: 327-36

•  Laban C, Bustin SA , Jenkins PJ ( 2003 ) The GH/IGF-I axis in breast cancer. Trends Endocrinol Metab 14:28-34

•  Kola B, Korbonits M, Kaltsas G, Morris DG, Metherell L, Powell P, Czirják S, Arnaldi G, Bustin SA , Boscaro M, Mantero F, Grossman AB ( 2003 ) Growth Hormone Receptor And Type 1 Insulin-Like Growth Factor Receptor Expression In Human Somatotroph Tumors. Clin Endocrinol (Oxf). 59: 328-38

•  Vithana EN, Abu-Safieh L, Bird AC,. Hunt DM, Bustin SA , Bhattacharya SS ( 2003 ) Expression of precursor RNA processing factor 31 ( PRPF31 ) mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular 'clue' for incomplete penetrance . Invest Ophthalmol Vis Sci. 44: 4204-4209

•  Banerjea A, Phillips SM, Dorudi S, Bustin SA . (2003) Colorectal cancers with mononucleotide microsatellite instability can be identified using microfabricated chip technology. Anal Biochem. 322: 130-133

•  Bustin SA , Siddiqi S, Ahmed S, Hands RE, Dorudi S (2004) Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 108:412-417

•  Phillips SM, Banerjea A, Feakins E, Li, S-R, Bustin SA , Dorudi S ( 2004 ) Antigen-specific activation of tumour infiltrating lymphocytes in colorectal cancer with microsatellite instability. Br J Surgery 91:469-475

•  Stamm DS, S. Dziennis S, Bustin SA , Sanderson IR (2004) Diet induces MHC class II expression in mouse intestinal epithelium through the regulatory molecule, CIITA IV Gastroenterology 127:203-212

•  Li, SR., Ng, CFJ, Banerjea, A, Ahmed, S, Hands, R, Powar, M, Ogunkolade, W. Dorudi, S, Bustin SA (2004) Differential expression patterns of the insulin-like growth factor II gene in human colorectal cancer Tumor Biology 25:62-68

•  Dheda, K., Huggett J, Bustin SA , Johnson M, Rook G, Zumla A ( 2004 ) Validation of housekeeping genes for normalising RNA expression in Tuberculosis. Biotechniques 37:112-119

•  Banerjea A, Ahmed S, Hands RE, Bustin SA, Dorudi S (2004) Colorectal Cancers with Microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer 6:21-29

•  Jenkins, PJ and Bustin SA (2004) Evidence for a link between IGF-I and cancer Eur J Endocrinol 151:S17-22

•  Bustin, SA ( 2004 ) Reacting in real-time. The Endocrinologist 71:9

•  Bustin, SA and Nolan T (2004) Pitfalls of Quantitative Real-Time PCR. J Biomol 15:155-166

•  Bustin SA, Dorudi S ( 2004 ) Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Exp Rev Mol 4:599-607

•  Banerjea A, Bustin SA , Dorudi S. ( 2005 ) The immunogenicity of colorectal cancers with high-degree microsatellite instability. World J Surg Oncol. 2005 May 12:26

•  Huggett J, Dheda K, Bustin SA , Zumla A. ( 2005 ) Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6:279-84.

•  Bustin SA , Nolan T, Benes V, Pfaffl M ( 2005 ) Real-time fluorescence-based PCR, J Mol Endocrinol 34:597-601

  •  Bustin SA , Mueller R ( 2005 ) Real-time reverse transcription PCR and its potential use in clinical diagnosis. Clinical Science 109:365-379

•  Dheda K., Huggett J, Chang JS, Kim LU, Bustin SA , Johnson M, Rook G, Zumla A ( 2005 ) The implications of using an inappropriate reference gene for real-time RT-PCR data normalisation. Anal Biochem 344:141-143

•  Ahmed S, Banerjea A, Hands RE, Bustin SA , Dorudi ( 2005 ) Microarray profiling of colorectal cancer in Bangladeshi patients. Colorectal Disease 7:571-575

•  Bustin, SA ( 2005 ) Real-time fluorescence-based quantitative PCR: a snapshot of current procedures and preferences. Exp. Rev. Mol. Diagn. 5:493-498

•  Jenkins, PJ, Khalaf, S, Ogunkolade, W, McCarthy, K, David, T, Hands, RE, Davies, D, Bustin, SA (2005) Differential expression of IGFBP-3 in normal and malignant colon and its influence on apoptosis. Endocrine-related Cancer 12:1-11

•  Banerjea A, Feakins RM, Nickols CD, Phillips SM, Powar MP, Bustin SA, Dorudi S ( 2005 ) Immunogenic HSP-70 is overexpressed in colorectal cancers with high-degree microsatellite instability. Dis. Colon Rectum 48:2322-2328

•  Bustin, SA Mueller, R. (2006) Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer. Mol. Aspects Medicine 27:192-223

•  Nolan T, Hands RE, Ogunkolade W, Bustin SA . (2006) SPUD: A quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem. 351:308-310.

•  Ogunkolade WB, Boucher BJ, Bustin SA, Burrin JM, Noonan K, Mannan N, Hitman GA. Vitamin D (2006) Metabolism in Peripheral Blood Mononuclear Cells is influenced by Chewing 'Betel nut' (Areca catechu) and Vitamin D Status. J Clin Endocrinol Metab. 91:2612-2617

•  McCarthy K, Bustin SA, Ogunkolade B, Khalaf S, Laban CA, McVittie CJ, Carpenter R, Jenkins PJ. (2006) Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer. Eur J Surg Oncol . 32:707-709  

•  Bustin, SA. (2006) Nucleic acid quantification and disease outcome prediction in colorectal cancer. Personalized Medicine (2006) 3(2), 207-216

•  McVittie C, Khalaf S, Ogunkolade W, McCarthy K, Laban C, Macaulay VM, Carpenter R, Bustin SA, Jenkins P. Extended silencing of the insulin-like growth factor-I receptor gene in MCF-7 cells by serial transfection with siRNA. Anal Biochem. 2006 Oct 15;357(2):305-7

•  Nolan T, Hands RE, Bustin SA.  Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3):1559-82.

•  Nolan T, Hands RE, Ogunkolade W, Bustin SA.  SPUD: a quantitative PCR assay for the detection of inhibitors in 
nucleic acid preparations. Anal Biochem. 2006 Apr 15;351(2):308-10.

•  Bustin SA, Mueller R. Real-time reverse transcription PCR and the detection of occult  disease in colorectal cancer. Mol Aspects Med. 2006 Apr-Jun;27(2-3):192-223

<< Return to profile

 

<< Return to staff list

 
Top
 
 
by Kerry Newbury. © Queen Mary, University of London 2005

Blizard Institute, Barts and The London School of Medicine and Dentistry, The Blizard Building, 4 Newark Street, London E1 2AT, UK Tel: +44 (0)20 7882 2483, Fax: +44 (0)20 7882 2200